BioSpace News Archive

Dr. Christian Hassig, CSO, scheduled to present at 10:00 a.m. ET on March 13, 2019

Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has been granted de novo classification by the U.S. Food and Drug Administration (FDA) for the Early Bird Bleed Monitoring System.

Landos Biopharma, Inc. announced the publication of findings that further characterize the safety profile of BT-11, its orally-active, gut-restricted investigational new drug for Crohn’s disease and ulcerative colitis, in the International Journal of Toxicology published in association with the American College of Toxicology.

Acerus Pharmaceuticals Corporation reported its financial results for the three and twelve-month period ended December 31, 2018.

Innocoll Holdings Limited announced that it has named Richard Fante as Chief Executive Officer and as a member of Inncoll’s Board of Directors, effective March 1.

Newron Pharmaceuticals S.p.A. announces its financial results and operational highlights for the year ended December 31, 2018 and provides an outlook for 2019.

Aerie Pharmaceuticals, Inc. announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present an Aerie overview and provide a business update in a fireside discussion at the following conferences in March.

CarynHealth, the small business association health plan brand of Association Health Plans of America, LLC, today announced that it has selected HSBSuite™ from HSBlox to power its “association in the box”, the next-generation approach to the small employer healthcare marketplace.

Proceeds of financing will fuel corporate development efforts and further buildout of artificial intelligence platform to accelerate drug discovery in bold mission to erase cancer

PolarityTE, Inc. announced that its platform technology will be featured at the U.S. House of Representatives’ Health Care Innovation Showcase in Washington, DC on March 7, 2019.